Every year a few people are affected by Duchenne muscular dystrophy and face a difficult future. Muscular tissue in their bodies is slowly degraded, leading to decreased mobility, respiratory problems, heart failure and premature death. Mathias Uhlén and Cristina Al-Khalili Szigyarto at KTH/SciLifeLab have now hopefully taken a step closer to development of new treatments for the disease.

Read full press release (in Swedish)